[go: up one dir, main page]

WO2001045560A1 - Procede pour determiner des indices relatifs au sang et dispositif correspondant - Google Patents

Procede pour determiner des indices relatifs au sang et dispositif correspondant Download PDF

Info

Publication number
WO2001045560A1
WO2001045560A1 PCT/RU1999/000507 RU9900507W WO0145560A1 WO 2001045560 A1 WO2001045560 A1 WO 2001045560A1 RU 9900507 W RU9900507 W RU 9900507W WO 0145560 A1 WO0145560 A1 WO 0145560A1
Authority
WO
WIPO (PCT)
Prior art keywords
channels
κanalοv
unit
blοκ
activity
Prior art date
Application number
PCT/RU1999/000507
Other languages
English (en)
Russian (ru)
Inventor
Valery Gennadievich Muzhikov
Original Assignee
Valery Gennadievich Muzhikov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valery Gennadievich Muzhikov filed Critical Valery Gennadievich Muzhikov
Priority to AU30866/00A priority Critical patent/AU3086600A/en
Priority to DE19983992T priority patent/DE19983992B4/de
Priority to PCT/RU1999/000507 priority patent/WO2001045560A1/fr
Publication of WO2001045560A1 publication Critical patent/WO2001045560A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6802—Sensor mounted on worn items
    • A61B5/681—Wristwatch-type devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4854—Diagnosis based on concepts of alternative medicine, e.g. homeopathy or non-orthodox
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle

Definitions

  • the shared indicator may not be disregarded.
  • the present invention is a non-invasive process.
  • Another offer of the invention is a description of the non-invasive designation of the various indicators in person. 2
  • the device contains a radiation source operating in the near-infrared region of the detector and located above the shared body part. They emit radiation through a separate part of the body and, through it, are received, the received signals are received and received by us
  • liver diseases are associated with certain changes in the biochemistry of the liver, for example, the content of bilirubin, white blood cells, and
  • the concentra- tion of indicators of the partition is divided in the form of a divided fraction
  • the channels are related to the function of the basic physical systems, as well as to the system and related to them,
  • a non-invasive method of separating the indicators of the use of devices is used for the use of non-invasive devices.
  • Task ⁇ edlagaem ⁇ g ⁇ iz ⁇ b ⁇ e ⁇ eniya yavlyae ⁇ sya ⁇ az ⁇ ab ⁇ a noninvariant zivn ⁇ g ⁇ s ⁇ s ⁇ ba ⁇ edeleniya u ⁇ vnya glyu ⁇ zy, d ⁇ ugi ⁇ bi ⁇ imiches ⁇ i ⁇ and ⁇ menny ⁇ ⁇ aza ⁇ eley ⁇ vi on ⁇ sn ⁇ vanii ⁇ tsen ⁇ i a ⁇ ivn ⁇ s ⁇ i ⁇ e- delonny ⁇ a ⁇ u ⁇ un ⁇ u ⁇ ny ⁇ ⁇ anal ⁇ v in ⁇ m including ⁇ ealn ⁇ m v ⁇ emeni in ⁇ ezhime ⁇ s ⁇ yann ⁇ g ⁇ m ⁇ ni ⁇ inga.
  • the energy activity of the channels can be divided up and
  • 25 ENG channel can be used in time intervals between ⁇ -
  • Glucose ⁇ vi 24 - 6.1 ⁇ + 6.4 ⁇ - 14 ⁇ - 4.0 ⁇ + 5.2 ⁇
  • stomach channels ( ⁇ ), the intestines are important.
  • Evaluation of the energy activity of the channels that are active can only be attributed to the fact that people are involved in the exploitation of human activity.
  • a number of surveys of one patient are conducted in the dynamics of his observation with the use of an individual model of dependencies.
  • ⁇ ⁇ ivedonny ⁇ in ⁇ isanii ⁇ ablitsa ⁇ for ene ⁇ ge ⁇ iches ⁇ i ⁇ ⁇ anal ⁇ v is ⁇ lz ⁇ vany ⁇ scheu ⁇ ebi ⁇ elnye ⁇ b ⁇ znacheniya: ⁇ - ⁇ anal log ⁇ i ⁇ , 01- ⁇ anal ⁇ ls ⁇ g ⁇ ⁇ ishechni ⁇ a, uS- ⁇ anal ⁇ e ⁇ i ⁇ a ⁇ da, ⁇ - ⁇ anal ⁇ yn ⁇ g ⁇ ⁇ b ⁇ g ⁇ eva ⁇ elya, C- ⁇ anal se ⁇ dtsa, 10- ⁇ ana ⁇ ⁇ n ⁇ g ⁇ ⁇ ishechni ⁇ a, ⁇ - ⁇ anal
  • the concentration of some indicators of the circle and, in particular, glucose are mainly estimated at the base of the 5 assets available.
  • 15 activities of the separate channels can be divided by results of the studies of differences in the age of the patient and the diagnosis of the group.
  • the evaluation of the channel’s activity level may occur with the help of the distribution of the activity of the channel associated with the activity of the channel.
  • Isomer and the rate of its concentration in the area is connected with the liver cells with a larger external component.
  • the basic function of the baking channel has an accessible level of glucose in the country, the general level of function.
  • the left side of the channel of the liver is associated with cells that have a left-hand side of the compressed air, which is associated with a reduction in the outcome of the disease.
  • the analogous regulatory channel mechanism has places and regulates the other components of the circuit. 14
  • the proposed method of quantitatively evaluating the indicators of profitability is carried out by the following method:
  • the 20th phase of research determines the indicators of the highest energy activity of the interesting channels of the channel. (For more details, see Application No. 98106432/14, publ. “Inventions”, ° 1, 2000)
  • 25 taxes may be paid to the test of Gabana, Folla, Kazakstani, etc.
  • ch ⁇ v ⁇ zdey- s ⁇ vuya ⁇ s ⁇ yannym ⁇ m ⁇ schn ⁇ s ⁇ i is ⁇ chni ⁇ m ⁇ e ⁇ la, schi ⁇ aya ⁇ i e ⁇ m v ⁇ e- on me in se ⁇ unda ⁇ on ⁇ edelonnye B ⁇ ⁇ anal ⁇ v or ⁇ dn ⁇ sya ⁇ it used ⁇ chni ⁇ ⁇ e ⁇ la ⁇ e ⁇ i ⁇ diches ⁇ i, na ⁇ ime ⁇ in ⁇ a ⁇ with ⁇ uls ⁇ m, ⁇ edelyayu ⁇ ⁇ - 5 liches ⁇ v ⁇ v ⁇ zdeys ⁇ vy / ⁇ ass ⁇ v / d ⁇ manifestations of painful sensations.
  • ⁇ n na ⁇ di ⁇ sya in gi ⁇ un ⁇ tsii ⁇ chisl ⁇ ⁇ e ⁇ l ⁇ vy ⁇ v ⁇ zdeys ⁇ vy d ⁇ ⁇ yavleniya b ⁇ levy ⁇ ⁇ schuscheny ⁇ ez ⁇ v ⁇ z ⁇ as ⁇ ae ⁇ ⁇ s ⁇ avneniyu with ⁇ bychnym s ⁇ s ⁇ yaniem and na ⁇ b ⁇ if ⁇ anal na ⁇ di ⁇ sya on vys ⁇ m ene ⁇ ge ⁇ iches ⁇ m u ⁇ vne in th gi ⁇ e ⁇ un ⁇ tsii, ⁇ chisl ⁇ ⁇ a ⁇ i ⁇ v ⁇ zdeys ⁇ vy d ⁇ ⁇ yavleniya b ⁇ levy ⁇ ⁇ schuscheny ⁇ ez ⁇ ⁇ adae ⁇ ,
  • test ⁇ pulses may also be used in the low-frequency generator GZ-111. Negative impulses synchronized with a pulsed wave were given to the ZL-107B LED.
  • two types of devices may be used. ⁇ One of them, a portable portable device, is being tested. In the event of a test involving the end-users and the IR-radiation, the results of the evaluation of the activity of the separate channels with the public are separate from the public
  • the proposed equipment may be available for you.
  • Us ⁇ ys ⁇ v ⁇ s ⁇ de ⁇ zhi ⁇ bl ⁇ ⁇ egis ⁇ atsii se ⁇ dechn ⁇ g ⁇ ⁇ i ⁇ ma (1) bl ⁇ u ⁇ avleniya (2) bl ⁇ da ⁇ chi ⁇ a v ⁇ emeni (3), and bl ⁇ ⁇ egis ⁇ atsii ⁇ b- ⁇ ab ⁇ i in ⁇ matsii (4) bl ⁇ ⁇ b ⁇ azheniya in ⁇ matsii (5) bl ⁇ bi- s ⁇ nneg ⁇ m ⁇ dema connection bl ⁇ bi- s ⁇ nneg ⁇ m ⁇ dema connection
  • Evaluation of the activity of the accelerator channels is carried out by the interference of the pulses of the IR-radiation
  • the control unit is equipped with a keypad for entering commands and information.
  • the unit of registration and processing of information was performed on a basic microprocessor (for example, on the basis of an independent process) ⁇
  • the IS-DIID type is Zi ⁇ P-107B.
  • the communication unit with the computer is based on the basic information of the two-sided interface, which allows the user to transmit information to the user.
  • the supplying pulses are transmitted to the B synchronously with the pulsed wave (using the pulse sensor) or the C-wave, through the synchronization via the EG-channel. With this, we count the number of test impulses for every other case of the outbreak of illness. If the channel is in a low power function, then the number of test pulses will be larger and more general level of the channel function.
  • the optional “self-learning of the system” is also possible due to the testing of all channels with simultaneous biomedical diseases.
  • the initial model is so long as it takes into account changes in the course of the disease and the other factors.
  • the sum of the values of the indicators of 24 channels is found for each of the channels in the channel model (in this case, it is equal to 168), and the average value is 7 (7). Then, each of the indicators for the channels is divided into the average value. The resulting result is entered in the formula. For women with diabetes mellitus 1 type of analogous adult group of the history of glucose dependence in the presence of an increase in the incidence of the disease.
  • the direct measurement of the glucose level for analyzing the glucose from the finger was 5.7 m / l.
  • Example 4 Patient G., 66 years. IB ⁇ 1785-s. It suffers from diabetes mellitus 2 and 2.
  • Table 8 The results of the channel test are presented in Table 8.
  • the level of glucose was 17.0 mols / l.
  • the level of the nation was 141 mol / l.
  • This method of valuation prevents the use of daily monitoring and other biological indicators of real time.
  • Leukocytes 2.93 + 0.63 ⁇ + 0.04 ⁇ - 0.26 ⁇ - 0.13 ⁇ + 0.02 ⁇
  • Eritocytes 4.1 + 0.02 ⁇ + 0.34 ⁇ - 0.14 ⁇ - 0.07 ⁇ + 0.02 ⁇
  • the proposed method went to medical treatment, in particular in one of the hospitals in the city of Saint-Petersburg, Russia. Question for the period 1998-1999 It was used to divide indicators of more than 250 patients.
  • the proposed method is available and allows reliable and reliable results to be obtained.
  • Devices for the implementation of a non-invasive method of separating indicators of convenience are convenient for use and can be used in daily operation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Optics & Photonics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Emergency Medicine (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne la médecine et notamment la diagnostique de laboratoire; elle sert à déterminer par procédé non invasif divers indices biochimiques et formels relatifs au sang humain, notamment le taux de glucose. On calcule les indices relatifs au sang sur la base d'une estimation quantitative de l'activité énergétique des canaux d'acupuncture du patient en utilisant des formules mathématiques, établies préalablement et correspondant à l'âge, au sexe, au diagnostic de la maladie du patient, qui déterminent la dépendance des indices relatifs au sang de la valeur de l'activité énergétique de canaux d'acupuncture déterminés. On établit les formules de dépendance par traitement mathématique des résultats d'une série d'examens. L'activité énergétique des canaux d'acupuncture peut être déterminée par l'action d'un rayonnement infrarouge modulé sur les points d''entrée/sortie' des canaux. Pour mettre en oeuvre le procédé de l'invention, on utilise un dispositif qui comprend un boîtier à l'intérieur duquel sont disposés une unité d'enregistrement du rythme cardiaque (1), une unité de commande (2), une unité horloge (3), une unité d'enregistrement et de traitement des informations (4), un bloc d'affichage (5) et un bloc de liaison avec l'ordinateur (6).
PCT/RU1999/000507 1999-12-21 1999-12-21 Procede pour determiner des indices relatifs au sang et dispositif correspondant WO2001045560A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU30866/00A AU3086600A (en) 1999-12-21 1999-12-21 Method for determining blood indexes and a device for embodying thereof
DE19983992T DE19983992B4 (de) 1999-12-21 1999-12-21 Verfahren zur Bestimmung von Blutcharakteristiken
PCT/RU1999/000507 WO2001045560A1 (fr) 1999-12-21 1999-12-21 Procede pour determiner des indices relatifs au sang et dispositif correspondant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU1999/000507 WO2001045560A1 (fr) 1999-12-21 1999-12-21 Procede pour determiner des indices relatifs au sang et dispositif correspondant

Publications (1)

Publication Number Publication Date
WO2001045560A1 true WO2001045560A1 (fr) 2001-06-28

Family

ID=20130426

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU1999/000507 WO2001045560A1 (fr) 1999-12-21 1999-12-21 Procede pour determiner des indices relatifs au sang et dispositif correspondant

Country Status (3)

Country Link
AU (1) AU3086600A (fr)
DE (1) DE19983992B4 (fr)
WO (1) WO2001045560A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958039B2 (en) 2003-05-02 2005-10-25 Oculir, Inc. Method and instruments for non-invasive analyte measurement
US6968222B2 (en) 2003-05-02 2005-11-22 Oculir, Inc. Methods and device for non-invasive analyte measurement
US6975892B2 (en) 2003-10-21 2005-12-13 Oculir, Inc. Methods for non-invasive analyte measurement from the conjunctiva

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2746036C1 (ru) * 2020-08-11 2021-04-06 Валерий Геннадьевич Мужиков Способ количественной оценки активности акупунктурных каналов, система и модуль для его осуществления

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0160768A1 (fr) * 1984-05-04 1985-11-13 Kurabo Industries Ltd. Dispositif spectrophotométrique pour la détermination, par voie non-invasive, de glucose dans les tissus vivants
RU2110248C1 (ru) * 1992-12-30 1998-05-10 Валерий Геннадьевич Мужиков Способ коррекции аритмий сердца, не связанных с органическими нарушениями, и устройство для рефлексотерапии
RU2122208C1 (ru) * 1989-10-28 1998-11-20 Сак Янг Вон Способ и устройство для измерения концентрации глюкозы в крови

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5383909A (en) * 1993-01-29 1995-01-24 Medtronic, Inc. Diagnostic telemetry system for an apparatus for detection and treatment of tachycardia and fibrillation
WO1996013201A1 (fr) * 1993-05-07 1996-05-09 Diasense, Inc. Procede non invasif de mesure de la concentration d'un analyte dans le sang
DE4342105A1 (de) * 1993-12-12 1995-06-14 Cho Ok Kyung Verfahren und Vorrichtung zur noninvasiven Bestimmung der Konzentration der Glucose in Teilen des menschlichen Körpers, inbesondere im menschlichen Blut, unter Durchführung höchstgenauer Temperaturmessungen des menschlichen Körpers
US5553613A (en) * 1994-08-17 1996-09-10 Pfizer Inc. Non invasive blood analyte sensor
AT610U1 (de) * 1995-01-23 1996-02-26 Knaipp Ortwin Mag Langzeit-pulsmess-armbanduhr mit speicher
DE19841217B4 (de) * 1997-10-27 2005-06-16 Applied Photonics Worldwide, Inc., Reno Gerät und Verfahren zur spektroskopischen Analyse von menschlichem oder tierischem Gewebe oder Körperfluiden

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0160768A1 (fr) * 1984-05-04 1985-11-13 Kurabo Industries Ltd. Dispositif spectrophotométrique pour la détermination, par voie non-invasive, de glucose dans les tissus vivants
RU2122208C1 (ru) * 1989-10-28 1998-11-20 Сак Янг Вон Способ и устройство для измерения концентрации глюкозы в крови
RU2110248C1 (ru) * 1992-12-30 1998-05-10 Валерий Геннадьевич Мужиков Способ коррекции аритмий сердца, не связанных с органическими нарушениями, и устройство для рефлексотерапии

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958039B2 (en) 2003-05-02 2005-10-25 Oculir, Inc. Method and instruments for non-invasive analyte measurement
US6968222B2 (en) 2003-05-02 2005-11-22 Oculir, Inc. Methods and device for non-invasive analyte measurement
US6975892B2 (en) 2003-10-21 2005-12-13 Oculir, Inc. Methods for non-invasive analyte measurement from the conjunctiva

Also Published As

Publication number Publication date
DE19983992B4 (de) 2009-07-23
DE19983992T1 (de) 2002-12-05
AU3086600A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
Umair et al. HRV and stress: A mixed-methods approach for comparison of wearable heart rate sensors for biofeedback
Vitale An integrative review of Reiki touch therapy research
Mossberg Reliability of a timed walk test in persons with acquired brain injury
Segman Device and method for noninvasive glucose assessment
EP0612500A1 (fr) Procede et dispositif pour le diagnostic d'un organisme vivant
WO2002087434A1 (fr) Procede d'evaluation de l'efficacite d'un etat biologique et d'une action modifiant un etat biologique, appareil et systeme d'evaluation, programme d'evaluation et support d'enregistrement dudit programme
JP2009515576A (ja) 高血圧等の心臓血管系疾患の管理又は制御のためのシステム及び方法
EP1221034B1 (fr) Procede et systeme d'imagerie de la dynamique d'un milieu de dispersion
Bowman et al. Counselor trainee anxiety during the initial counseling interview.
Armour et al. Reliability and validity in quantitative and qualitative research
Niranjan et al. Machine learning based analysis of pulse rate using Panchamahabhutas and Ayurveda
WO2020221265A1 (fr) Appareil et méthode de surveillance de la concentration de constituants du sang humain non invasifs
US7937139B2 (en) Systems and methods of utilizing electrical readings in the determination of treatment
US6527730B2 (en) Reducing noise in a technique for diagnosing attention deficit hyperactivity disorder
EP1219233A2 (fr) Diagnostic et traitement du trouble déficitaire de l'attention avec hyperactivité à l'aide de modification d'images et de biorétroaction en température
Drachev et al. Study profile: Oral health assessment among participants of “Epidemiology of cardiovascular diseases in Russian regions. Third study” in the Arkhangelsk region
WO2001045560A1 (fr) Procede pour determiner des indices relatifs au sang et dispositif correspondant
Paraschiv et al. An algorithm for quantifying anxiety, stress, and attention: towards objective assessment of mental states
Bundzen et al. Psychophysiological correlates of athletic success in athletes training for the Olympics
GB2410084A (en) Brain activity infra-red measurement device
Tarnanas et al. Functional impairment in virtual-reality-daily-living-activities as a defining feature of amnestic mci: Cognitive and psychomotor correlates
KR20130062858A (ko) 다파장 광 스캐닝을 통한 건강 상태 모니터링 장치 및 건강 상태 모니터링 서비스 제공 방법
WO1998035645A1 (fr) Procede diagnostique et pronostique concernant l'etat de l'organisme
Nazareth et al. Estimation of cholesterol in the presence of urea and other constituents in blood tissue
Oyama-Higa et al. Possibility of mental health self-checks using divergence of pulse waves

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CH CN CZ DE FI HU IL JP KR NO NZ PL RU SK UA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
RET De translation (de og part 6b)

Ref document number: 19983992

Country of ref document: DE

Date of ref document: 20021205

WWE Wipo information: entry into national phase

Ref document number: 19983992

Country of ref document: DE

122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8607

REG Reference to national code

Ref country code: DE

Ref legal event code: 8607

REG Reference to national code

Ref country code: DE

Ref legal event code: 8607